DAXOR CORPORATION - CLOSED END FUND
8.6075
04-October-24 12:52:20
15 minutes delayed
Stocks
-0.3525
-3.93%
Today's range
8.6075 - 9.0050
ISIN
N/A
Source
NASDAQ
-
28 Aug 2023 16:05:00 By Nasdaq GlobeNewswire
-
JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®
10 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
12 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
11 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
05 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering
22 Jun 2023 16:15:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services
15 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference
12 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
25 May 2023 15:37:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
22 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Announces Proposed Underwritten Public Offering
19 May 2023 16:53:00 By Nasdaq GlobeNewswire
-
18 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
20 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
17 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
13 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
27 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
23 Mar 2023 08:30:00 By Nasdaq GlobeNewswire
-
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
03 Mar 2023 08:00:00 By Nasdaq GlobeNewswire